|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2011-5-23
|
|
pubmed:abstractText |
The growing burden and morbidity of chronic kidney disease (CKD) warrant effective strategies for identifying those at increased risk. We examined the association of cystatin C level and albuminuria with the development of CKD stage 3.
|
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/K24 078204,
http://linkedlifedata.com/resource/pubmed/grant/K24 DK078204-04,
http://linkedlifedata.com/resource/pubmed/grant/K24 DK078204-05,
http://linkedlifedata.com/resource/pubmed/grant/N01-HC-95159,
http://linkedlifedata.com/resource/pubmed/grant/N01-HC-95160,
http://linkedlifedata.com/resource/pubmed/grant/N01-HC-95161,
http://linkedlifedata.com/resource/pubmed/grant/N01-HC-95162,
http://linkedlifedata.com/resource/pubmed/grant/N01-HC-95163,
http://linkedlifedata.com/resource/pubmed/grant/N01-HC-95164,
http://linkedlifedata.com/resource/pubmed/grant/N01-HC-95165,
http://linkedlifedata.com/resource/pubmed/grant/N01-HC-95166,
http://linkedlifedata.com/resource/pubmed/grant/N01-HC-95167,
http://linkedlifedata.com/resource/pubmed/grant/N01-HC-95168,
http://linkedlifedata.com/resource/pubmed/grant/N01-HC-95169
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1523-6838
|
|
pubmed:author |
pubmed-author:CushmanMaryM,
pubmed-author:JacobsDavid RDRJr,
pubmed-author:KatzRonitR,
pubmed-author:KestenbaumBryanB,
pubmed-author:KramerHollyH,
pubmed-author:PeraltaCarmen ACA,
pubmed-author:SarnakMark JMJ,
pubmed-author:ShastriShaniS,
pubmed-author:ShlipakMichael GMG,
pubmed-author:SiscovickDavidD,
pubmed-author:de BoerIan HIH
|
|
pubmed:copyrightInfo |
Copyright © 2011 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
57
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
832-40
|
|
pubmed:meshHeading |
pubmed-meshheading:21296473-Aged,
pubmed-meshheading:21296473-Aged, 80 and over,
pubmed-meshheading:21296473-Albuminuria,
pubmed-meshheading:21296473-Biological Markers,
pubmed-meshheading:21296473-Cystatin C,
pubmed-meshheading:21296473-Disease Progression,
pubmed-meshheading:21296473-Ethnic Groups,
pubmed-meshheading:21296473-Female,
pubmed-meshheading:21296473-Follow-Up Studies,
pubmed-meshheading:21296473-Glomerular Filtration Rate,
pubmed-meshheading:21296473-Humans,
pubmed-meshheading:21296473-Kidney Failure, Chronic,
pubmed-meshheading:21296473-Male,
pubmed-meshheading:21296473-Middle Aged,
pubmed-meshheading:21296473-Nephelometry and Turbidimetry,
pubmed-meshheading:21296473-Prognosis,
pubmed-meshheading:21296473-Retrospective Studies,
pubmed-meshheading:21296473-Risk Factors
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA).
|
|
pubmed:affiliation |
Tufts Medical Center, 800 Washington St., Boston, MA 02111, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Multicenter Study,
Research Support, N.I.H., Extramural
|
